Arctic Blue Beverages AB (”Arctic Blue Beverages” eller ”Bolaget”) har presenterat Bolagets Q1-rappo...
Redeye concludes that the figures in the report exceeded our expectations.
Redeye retains its positive view on Lagercrantz following a Q4 report in-line with our estimates.
Redeye provides a reseach update following the Q1 2024 report from Fragbite Group.
Redeye returns with a research update following Xbrane’s Q1 report.
Better Collective has acquired AceOdds which is a UK focused sports media company with products incl...
Redeye updates on Raketech after its Q1-results where performance was softer than expected, mainly d...
We make minor cuts to our estimates after Ferronordic's Q1 results.
Soft Q1 combined with a downgrade of the FY'24 guidance Synergies unlikely to show in '24e: cutting ...
Redeye leaves a research update following Klaria Pharma’s recently published Q1 2024 report.
Q1 revenues 4% below ABGSCe, EBIT DKK 10m vs. ABGSCe 33m FY'24 guidance downgraded following more in...
VBG Group fortsätter leverera starka resultat. Bolaget gynnas av en stark efterfrågan inom bussegmen...
Pharma Equity Group published its Q1 report for 2024 on the 16th of May, 2024.
Redeye provides its initial comments following the Q1 2024 report from Fragbite Group.
Alla tillstånd är på plats och gruvbrytning i Fäbodtjärn kan starta.
First Venture publicerade den 15 maj 2024 bolagets delårsrapport för det första kvartalet av 2024.
Q1 EBITDAC below on costs, reiterates FY'24 guidance Expect continued positive momentum New guidance...
Revenues and EBIT increase by 6 and 65% Order intake of DKK 1,254 misses our forecast by 26%.
Zoomability publicerade den 15 maj 2024 bolagets delårsrapport för årets första kvartal 2024.
Idag publicerade Fable Media sin delårsrapport för kv1 2024.
